Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma: a single institution's experience.

Tas, Faruk; Kurul, Sidika; Camlica, Hakan; Topuz, Erkan

Tas, Faruk; Kurul, Sidika; Camlica, Hakan; Topuz, Erkan.

Affiliation

Tas F; Institute of Oncology, Istanbul University, Turkey. faruktas2002@yahoo.com

Med Oncol ; 23(4): 471-7, 2006.

Article in En | MEDLINE | ID: mdl-17303905

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Interferon-alpha/therapeutic use; Melanoma/drug therapy; Skin Neoplasms/drug therapy; Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Female; Humans; Male; Melanoma/mortality; Middle Aged; Skin Neoplasms/mortality; Survival Analysis; Survival Rate

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Skin Neoplasms / Interferon-alpha / Angiogenesis Inhibitors / Melanoma Type of study: Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2006 Type: Article

Search on Google

XML

PubMed Links